Biomedical Science Letters

eISSN 2288-7415

Table. 1.

Correlation between SAMD13 and clinicopathological characteristics in HCC

Clinicopathological characteristics Overall survival (n = 3,218) Relapse free survival (n = 2,809) Progression free survival (n = 3,162) Disease specific survival (n = 3,189)
N Hazard ratio P-value N Hazard ratio P-value N Hazard ratio P-value N Hazard ratio P-value
SEX
Male 246 2.63
(1.64~4.21)		 3e-05 210 1.38
(0.92~2.05)		 0.11 149 1.45
(1.01~2.07)		 0.043 244 2.79
(1.53~5.09)		 0.00049
Female 118 1.5
(0.85~2.66)		 0.16 106 1.46
(0.81~2.64)		 0.21 121 1.61
(0.96~2.7)		 0.07 118 2.04
(0.98~4.25)		 0.052
STAGE
I 170 1.45
(0.79~2.67)		 0.23 153 1.16
(0.68~1.99)		 0.59 171 1.18
(0.72~1.94)		 0.51 168 1.63
(0.67~3.96)		 0.28
I+II 253 1.82
(1.12~2.95)		 0.014 228 1.36
(0.9~2.06)		 0.15 256 1.45
(0.99~2.12)		 0.053 251 2.75
(1.33~5.69)		 0.0044
II 83 2.7
(1.16~6.27)		 0.016 75 0.87
(0.45~1.69)		 0.68 85 1.09
(0.61~1.97)		 0.77 83 3.19
(0.98~10.4)		 0.042
II+III 166 2.17
(1.33~3.54)		 0.0015 145 1.24
(0.8~1.93)		 0.34 170 1.25
(0.84~1.85)		 0.28 166 2.12
(1.15~3.92)		 0.014
III 83 2.09
(1.13~3.84)		 0.016 70 1.77
(0.97~3.23)		 0.062 85 1.4
(0.82~2.41)		 0.22 83 1.64
(0.8~3.36)		 0.17
III+IV 87 1.74
(0.97~3.11)		 0.058 70 1.77
(0.97~3.23)		 0.062 90 1.41
(0.83~2.39)		 0.2 87 1.56
(0.78~3.13)		 0.21
IV 4 - - 0 - 5 - - 3 - -
GRADE
I 65 2.05
(0.78~5.39)		 0.14 55 1.96
(0.74~5.23)		 0.17 55 4
(1.7~9.41)		 0.00067 55 5.11
(1.29~20.22)		 0.011
II 174 2
(1.18~3.38)		 0.0086 149 1.38
(0.85~2.25)		 0.19 177 1.36
(0.88~2.1)		 0.16 171 2.03
(1.03~3.97)		 0.036
III 118 2.02
(1.09~3.77)		 0.023 107 1.28
(0.75~2.18)		 0.37 121 1.29
(0.78~2.12)		 0.32 119 1.78
(0.83~3.82)		 0.13
IV 12 - - 11 - - 12 - - 12 - -
AJCC_T
I 180 1.37
(0.77~2.46)		 0.28 160 1.16
(0.69~1.97)		 0.57 181 1.18
(0.73~1.91)		 0.49 178 1.4
(0.62~3.13)		 0.41
II 90 2.52
(1.17~5.43)		 0.015 80 0.91
(0.49~1.71)		 0.77 93 1.15
(0.67~1.99)		 0.61 91 2.74
(1.01~7.42)		 0.039
III 78 2.12
(1.13~3.96)		 0.016 67 1.59
(0.85~2.96)		 0.14 80 1.25
(0.71~2.19)		 0.44 77 1.72
(0.81~3.65)		 0.15
IV 13 - 6 13 13 - -
Vascular invasion
None 203 1.46
(0.87~2.44)		 0.15 175 1.09
(0.68~1.77)		 0.71 205 1.05
(0.67~1.64)		 0.83 201 1.37
(0.67~2.8)		 0.38
Micro 90 1.5
(0.7~3.21)		 0.29 82 1.13
(0.6~2.12)		 0.71 92 1.25
(0.71~2.21)		 0.43 90 1.44
(0.48~4.28)		 0.51
Macro 16 - - 14 - - 16 - - 14 - -
RACE
White 181 1.55
(0.98~2.47)		 0.059 147 1.58
(1~2.49)		 0.046 184 1.57
(1.05~2.33)		 0.026 179 2.23
(1.24~4)		 0.006
Asian 154 2.57
(1.37~4.81)		 0.0022 145 1.35
(0.82~2.24)		 0.24 157 1.6
(1~2.57)		 0.048 154 2.4
(1.08~5.37)		 0.028
Alcohol consumption
Yes 115 1.27
(0.67~2.39)		 0.46 99 0.94
(0.53~1.68)		 0.84 117 1.07
(0.64~1.79)		 0.79 117 1.14
(0.56~2.32)		 0.72
None 202 1.81
(1.14~2.88)		 0.011 183 1.43
(0.92~2.22)		 0.11 205 1.47
(0.99~2.21)		 0.057 199 2.15
(1.14~4.04)		 0.015
Hepatitis virus
Yes 150 1.23
(0.64~2.34)		 0.54 139 0.93
(0.57~1.53)		 0.78 153 1.07
(0.67~1.69)		 0.78 151 1.76
(0.77~4.02)		 0.18
None 167 1.79
(1.13~2.84)		 0.012 133 1.58
(0.95~2.6)		 0.074 169 1.63
(1.05~2.53)		 0.028 165 1.95
(1.09~3.47)		 0.021
Biomed Sci Letters 2022;28:260-75 https://doi.org/10.15616/BSL.2022.28.4.260
© 2022 Biomed Sci Letters